Suven Life Sciences provide financial assistance of Rs 70 lakh to Bharosa

Published On 2019-03-17 04:51 GMT   |   Update On 2019-03-17 04:51 GMT

Suven Life Sciences has also agreed to provide contribute yearly maintenance cost of Rs 30 lakh over the next five years for the centre.


Hyderabad: As part of their Corporate Social Responsibility(CSR), Suven Life Sciences has donated an amount of Rs 70 lakh to 'Bharosa', a support centre for women and children, to enable it to construct SHE-Bharosa centre in Suryapet district. According to recent media reports, it has also agreed to provide contribute yearly maintenance cost of Rs 30 lakh over the next five years for the centre.


Bharosa, the Hyderabad police’s support centre for women and children, signed a Memorandum of Agreement (MoA) with Suven Life Sciences.


Also Read: Suven Life Sciences secures Product Patents in Australia and Singapore


The memorandum of agreement (MoA) was signed in the presence of Director-General of Police, M Mahendar Reddy, Suven Trust Managing Trustee Venkat Jasti, Additional Director-General of Police Jitender, Inspector General of Police (Law & Order) and In-Charge (Women Safety) Swati Lakra and other officials.





The MoA’s objective was to financially support SHE-Bharosa centre by funding it for next five years and to strengthen and popularize women and child protection initiatives. Another objective was to sensitize women and children about safety and security as well as support services available during crisis, reports Telangana Today.


SHE Teams was introduced in the state in 2014 with a motto to provide safety and security to women and to curb crimes against women. Bharosa is an integrated support centre for women and children that was established by the city police in 2016. The centre helps resolve conflicts in families and provides services related to police, medical, legal and psycho-therapeutic counselling.


Suven Life Sciences Ltd. (Suven) is an Indian life sciences company based in Hyderabad, Telangana, India. Established in 1989 as a private limited company, it went public in 1995. The company designs, manufactures and supplies bulk actives, drug intermediates and fine chemicals to domestic and international players in the bio-pharmaceuticals industry.









Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News